The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors may perhaps lead to an increase in oxycodone plasma concentrations, which could increase or prolong adverse reactions and will result in most likely lethal respiratory despair. Moreover, discontinuation of a concomitantly applied cytochrome P450 3A4 inducer may perhaps end… Read More